Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors
- PMID: 12110993
- DOI: 10.1007/s00213-002-1070-x
Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors
Abstract
Rationale: The differential reinforcement of low-rate 72-s (DRL 72-s) schedule, in which rats must withhold a response for at least 72 s to obtain a reward (generally water), is an attractive procedure for the characterisation of potential antidepressant agents. Indeed, several antidepressants have been shown to improve efficiency (ratio of reinforcement rate to response rate) in this model, either by decreasing response rates and/or by increasing reinforcement rates.
Objective: Herein, we compared the actions of antidepressants known to inhibit serotonin (5-HT), norepinephrine (NE) and/or dopamine (DA) reuptake in a food-rewarded DRL 72-s schedule.
Methods: Rats trained in a food-rewarded DRL 72-s schedule and showing stable baseline performance were administered with drugs i.p. once a week. In independent experiments, the influence of drugs on food intake, spontaneous locomotor activity and extracellular levels of monoamines in the frontal cortex was evaluated.
Results: In confirmation of previous studies, the tricyclic agent imipramine (10.0 mg/kg) and the "atypical" agent mianserin (40.0 mg/kg) significantly increased efficiency. In analogy, the selective NE reuptake inhibitors (NARIs) desipramine (20.0 mg/kg), nortriptyline (2.5 mg/kg) and reboxetine (0.63 mg/kg) all displayed marked enhancements in efficiency. In contrast, the selective 5-HT reuptake inhibitors (SSRIs) citalopram (10.0 mg/kg), fluvoxamine (10.0 mg/kg) and paroxetine (10.0 mg/kg) all significantly decreased efficiency. The mixed 5-HT/NE reuptake inhibitors (SNRIs) venlafaxine (2.5 mg/kg, 10.0 mg/kg) and S33005 (0.16-10.0 mg/kg), likewise, did not increase efficiency. Further, the DA reuptake inhibitors (DARIs) bupropion (0.16-10.0 mg/kg) and GBR12935 (0.63-10.0 mg/kg) had no effect on DRL 72-s performance. All drug classes exerted a similar, mild inhibitory influence on food intake and locomotor behaviour. Imipramine, mianserin and NARIs markedly increased extracellular levels of NE, and SSRIs elevated levels of 5-HT, while SSRIs augmented levels of both.
Conclusions: The present experimental procedure demonstrates, in analogy to imipramine and mianserin, robust and consistent increases in efficiency with NARIs. Their effects may be distinguished from a decrease in efficiency elicited by SSRIs, and a lack of activity of SNRIs and DARIs. While the reasons underlying the ineffectiveness of SSRIs (in contrast to previous studies) remain to be clarified, these data underline the importance of adrenergic mechanisms in the control of behaviour under conditions of delayed responding. Further, they support the interest of DRL 72-s procedures for the characterisation of diverse classes of antidepressant agent.
Similar articles
-
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.Pharmacol Biochem Behav. 2002 Apr;71(4):667-80. doi: 10.1016/s0091-3057(01)00701-8. Pharmacol Biochem Behav. 2002. PMID: 11888558
-
Discriminative stimulus properties of antidepressant agents: a review.Behav Pharmacol. 2003 Sep;14(5-6):391-407. doi: 10.1097/01.fbp.0000089141.24369.07. Behav Pharmacol. 2003. PMID: 14501253 Review.
-
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.Psychopharmacology (Berl). 2001 Nov;158(2):213-8. doi: 10.1007/s002130100895. Psychopharmacology (Berl). 2001. PMID: 11702096
-
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.Psychopharmacology (Berl). 2007 Jun;192(3):357-71. doi: 10.1007/s00213-007-0728-9. Epub 2007 Feb 21. Psychopharmacology (Berl). 2007. PMID: 17318507
-
The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.CNS Neurosci Ther. 2011 Dec;17(6):723-32. doi: 10.1111/j.1755-5949.2010.00217.x. Epub 2010 Dec 14. CNS Neurosci Ther. 2011. PMID: 21155988 Free PMC article. Review.
Cited by
-
The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.CNS Drug Rev. 2004 Spring;10(1):23-44. doi: 10.1111/j.1527-3458.2004.tb00002.x. CNS Drug Rev. 2004. PMID: 14978512 Free PMC article. Review.
-
Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter.Pharmacol Biochem Behav. 2012 Jan;100(3):419-24. doi: 10.1016/j.pbb.2011.10.003. Epub 2011 Oct 8. Pharmacol Biochem Behav. 2012. PMID: 22005597 Free PMC article.
-
The selective serotonin reuptake inhibitor paroxetine decreases breakpoint of rats engaging in a progressive ratio licking task for sucrose and quinine solutions.Chem Senses. 2013 Mar;38(3):211-20. doi: 10.1093/chemse/bjs096. Epub 2012 Dec 19. Chem Senses. 2013. PMID: 23254343 Free PMC article.
-
α₂- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity.Psychopharmacology (Berl). 2012 Jul;222(2):237-45. doi: 10.1007/s00213-012-2635-y. Epub 2012 Jan 21. Psychopharmacology (Berl). 2012. PMID: 22271065
-
Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment.Psychopharmacology (Berl). 2008 Jul;199(1):1-14. doi: 10.1007/s00213-007-1035-1. Epub 2008 May 10. Psychopharmacology (Berl). 2008. PMID: 18470507
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources